What's new in the National Asthma Education and Prevention Program (NAEPP) 2002 guidelines

Advanced Studies in Medicine

Volumn 3, Issue 7, 2003, Pages 379-390+416

  Stempel, David A ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUNISOLIDE; FLUTICASONE; FORMOTEROL; LEUKOTRIENE RECEPTOR AFFECTING AGENT; METHYLPREDNISOLONE; MONTELUKAST; NEDOCROMIL; PREDNISOLONE; PREDNISONE; SALMETEROL; THEOPHYLLINE; TRIAMCINOLONE; ZAFIRLUKAST; ZILEUTON;

ANTIBIOTIC THERAPY; ASTHMA; CORTICOSTEROID THERAPY; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW;

EID: 0042378457     PISSN: 15303004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. National Asthma Education and Prevention Program (NAEPP). Clinical Practice Guidelines. Expert Panel Report 2. Guidelines for the Diagnosis and Management of Asthma. Bethesda, Md: National Institutes of Health; 1997. Publication 97-4051.
2. National Asthma Education and Prevention Program (NAEPP). NAEPP Expert Panel Report. Guidelines for the Diagnosis and Management of Asthma - Update on Selected Topics 2002. J Allergy Clin Immunol. 2002;110(suppl 5):S141-S219. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/index.htm. Accessed June 24, 2003.
3. Mannino DM, Homa DM, Akinbami IJ, Moorman JE, Gwynn C, Redd SC. Surveillance for asthma-United States, 1980-1999. MMWR Surveill Summ. 2002;51(1):1-13.
4. Weiss ST. Epidemiology and heterogeneity of asthma. Ann Allergy Asthma Immunol. 2001;87 (1, suppl 1):5-8.
5. National Institutes of Health. National Heart, Lung, and Blood Institute. Global Initiative for Asthma (GINA). Strategy for asthma management and prevention. Bethesda, Md: National Institutes of Health; 2002. Publication 02-3659. Available at: http://www.ginasthma.com. Accessed April 12, 2003.
6. Self-reported asthma prevalence among adults-United States, 2000. MMWR Morb Mortal Wkly Rep. 2001;50(32):682-686.
7. American Lung Association, Epidemiology & Statistics Unit. February 2002. Trends in asthma morbidity and mortality. January 2001. New York: American Lung Association; 2002. Available at: http://www.lungusa.org/data/asthma/asthmach_index.html. Accessed April 12, 2003.
8. Asthma in America: a landmark survey. GlaxoSmithKline; Research Triangle Park, NC. Available at: www.asthmainamerican.com. Accessed April 12, 2003.
9. Calhoun WJ. Management of asthma in the United States: where do we stand? Adv Studies Med. 2002;2(1):8-13.
10. Suh DC, Shin SK, Okpara I, Voytovich RM, Zimmerman A. Impact of a targeted asthma intervention program on treatment costs in patients with asthma. Am J Manag Care. 2001;7(9):897-906.
11. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet. 1994;344(8917):219-224.
12. Evans DJ, Taylor DA, Zelterstrom O, Chung KF, O'Connor BJ, Barnes PJ. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med. 1997;337(20):1412-1418.
13. Stempel DA, O'Donnell JC, Meyer JW. Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs. J Allergy Clin Immunol. 2002;109(3):433-439.
14. O'Connor RD, O'Donnell JC, Pinto LA, Wiener DJ, Legorreta AP. Two-year retrospective economic evaluation of three dual-controller therapies used in the treatment of asthma. Chest. 2002;121(4):1028-1035.
15. Suissa S, Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol. 2001;107(6):937-944.
16. Goldman M, Rachmiel M, Gendler L, Katz Y. Decrease in asthma mortality rate in Israel from 1991-1995: is it related to increased use of inhaled corticosteroids. J Allergy Clin Immunol. 2000;105(1, pt 1):71-74.
17. Diette GB, Skinner EA, Nguyen TT, Markson L, Clark BD, Wu AW. Comparison of quality of care by specialist and generalist physicians as usual source of asthma care for children. Pediatrics. 2001;108(2):432-437.
18. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000;161(5):1720-1745.
19. Moore WC, Hasday JD, Meltzer SS, Wisnewski PL, White B, Bleecker ER. Subjects with mild and moderate asthma respond to segmental allergen challenge with similar, reproducible, allergen-specific inflammation. J Allergy Clin Immunol. 2001;108(6):908-914.
20. Laitinen LA, Laitinen A, Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol. 1992;90(1):32-42.
21. van den Toorn LM, Overbeek SE, de Jongste JC, Leman K, Hoogsteden HC, Prins JB. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med. 2001; 164(11):2107-2113.
22. Kendrick AH, Higgs CM, Whitfield MJ, Laszlo G. Accuracy of perception of severity of asthma: patients treated in general practice. BMJ. 1993; 307(6901):422-424.
23. Liard R, Leynaert B, Zureik M, Beguin FX, Neukirch F. Using Global Initiative for Asthma guidelines to assess asthma severity in populations. Eur Respir J. 2000;16(4):615-620.
24. Agency for Healthcare Research and Quality. Management of chronic asthma. Rockville, Md: Agency for Healthcare Research and Quality; 2001. Publication 01-EO44.
25. Silverstein MD, Yunginger JW, Reed CE, et al. Attained adult height after childhood asthma: effect of glucocorticoid therapy. J Allergy Clin Immunol. 1997;99(4):466-474.
26. Van Bever HP, Desager KN, Lijssens N, Weyler JJ, Du Caju MV. Does treatment of asthmatic children with inhaled corticosteroids affect their adult height? Pediatr Pulmonol. 1999;27(6):369-375.
27. Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med. 2000; 343(15):1064-1069.
28. Agertoft L, Larsen FE, Pedersen S. Posterior subcapsular cataracts, bruises and hoarseness in children with asthma receiving long-term treatment with inhaled budesonide. Eur Respir J. 1998;12(1):130-135.
29. Ip M, Lam K, Yam L, Kung A, Ng M. Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest. 1994;105(6):1722-1727.
30. Scott MB, Skoner DP. Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma. J Allergy Clin Immunol. 1999;104(4, pt 2):200-209.
31. Price JF, Russell G, Hindmarsh PC, Weller P, Heaf DP, Williams J. Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma. Pediatr Pulmonol. 1997; 24(3):178-186.
32. Gonzalez Perez-Yarza E, Mintegui J, Garmendia A, et al. The excretion of free cortisol in the urine in healthy children and in asthmatics treated with long-term inhaled glucocorticoids. Ann Esp Pediatr. 1996;44(6):531-536.
33. Nassif E, Weinberger M, Sherman B, Brown K. Extrapulmonary effects of maintenance corticosteroid therapy with alternate-day prednisone and inhaled beclomethasone in children with chronic asthma. J Allergy Clin Immunol. 1987;80(4):518-529.
34. Ribeiro LB. Budesonide: safety and efficacy aspects of its long-term use in children. Pediatr Allergy Immunol. 1993;4(2):73-78.
35. Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med. 2000;343(15):1054-1063.
36. Jonasson G, Carlsen KH, Blomqvist P. Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids. Eur Respir J. 1998;12(5): 1099-1104.
37. Simons FE. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. N Engl J Med. 1997;337(23):1659-1665.
38. Hoekstra MO, Grol MH, Bouman K, et al. Fluticasone propionate in children with moderate asthma. Am J Respir Crit Care Med. 1996;154(4, pt 1):1039-1044.
39. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med. 1994;88(5):373-381.
40. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis. 1992;146(3):547-554.
41. Storr J, Lenney CA, Lenney W. Nebulised beclomethasone dipropionate in preschool asthma. Arch Dis Child. 1986;61(3):270-273.
42. Connett GJ, Warde C, Wooler E, Lenney W. Use of budesonide in severe asthmatics aged 1-3 years. Arch Dis Child. 1993;69(3):351-355.
43. Verberne AA, Frost C, Roorda RJ, van der Laag H, Kerrebijn KF. One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group. Am J Respir Crit Care Med. 1997;156(3, pt 1):688-695.
44. Tinkelman DG, Reed CE, Nelson HS, Offord KP. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics. 1993;92(1):64-77.
45. Lagerlov P, Veninga CC, Muskova M, et al. Asthma management in five European countries: doctors' knowledge, attitudes and prescribing behaviour. Drug Education Project (DEP) group. Eur Respir J. 2000;15(1):25-29.
46. Graham V, Lasserson T, Rowe BH. Antibiotics for acute asthma. Cochrane Database Syst Rev. 2001;(3):CD002741.
47. Ducharme FM, Hicks GC. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database Syst Rev. 2002;(3):CD002314.
48. Toelle BG, Ram FS. Written individualised management plans for asthma in children and adults. Cochrane Database Syst Rev. 2002;(3):CD002171.